MitoChem Therapeutics collaborates with industry and research partners to accelerate breakthrough therapies targeting FUS biology and mitochondrial dysfunction. We welcome opportunities in co-development, licensing, and strategic research alliances across ALS/FTD, retinal disease, and related neurodegenerative indications.

Please contact us if you are interested in exploring partnership opportunities: contact@mitocheminc.com